Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Julie Hill Biography and Net Worth

Director of Elevance Health

Julie A. Hill is Independent Director of Anthem, Inc. Ms. Hill served on the former WellPoint Health Networks Inc. (“WHN”) board of directors from March 1994 until WHN’s merger with us in November 2004. Since 2002, she has been the owner of The Hill Company (real estate company). From 1998 to 2002, Ms. Hill was the President and owner of Hiram-Hill Development Company (residential real estate development firm). Prior thereto, she was the Chairman, President and Chief Executive Officer of Costain Homes, Inc. (home builders), the U.S. division of Costain Group Plc, a London-based company, from 1988 to 1997. Ms. Hill has served as a director of the Lord Abbett Family of Mutual Funds (mutual funds) since 2005 and previously served as a director of UNYQ (provider of orthopedic devices) from 2017 until 2019. She is chair of the University of California at Irvine Board of Trustees and serves as a member of the advisory boards of the Paul Merage School of Business Center for Real Estate, the UC Irvine School of Law Board of Visitors, the School of Social Ecology Dean’s Leadership Council, the Susan Samueli Center of Integrative Medicine, and the Paul Merage School of Business Center for Digital Transformation.

What is Julie A. Hill's net worth?: The estimated net worth of Julie A. Hill is at least $11.42 million as of May 20th, 2021. Ms. Hill owns 31,213 shares of Elevance Health stock worth more than $11,422,709 as of December 21st. This net worth estimate does not reflect any other investments that Ms. Hill may own. Learn More about Julie A. Hill's net worth.
How do I contact Julie A. Hill?: The corporate mailing address for Ms. Hill and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Julie A. Hill's contact information.
Has Julie A. Hill been buying or selling shares of Elevance Health?: Julie A. Hill has not been actively trading shares of Elevance Health within the last three months. Most recently, Julie A. Hill sold 1,308 shares of the business's stock in a transaction on Thursday, May 20th. The shares were sold at an average price of $394.00, for a transaction totalling $515,352.00. Following the completion of the sale, the director now directly owns 31,213 shares of the company's stock, valued at $12,297,922. Learn More on Julie A. Hill's trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 10/18/2024.

Julie A. Hill Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/20/2021	Sell	1,308	$394.00	$515,352.00	31,213
5/19/2020	Sell	1,102	$283.26	$312,152.52	31,822
1/31/2019	Sell	500	$299.75	$149,875.00
11/8/2018	Sell	500	$287.25	$143,625.00	34,327
8/16/2018	Sell	248	$267.01	$66,218.48	34,827
5/25/2018	Sell	1,000	$233.00	$233,000.00	35,075
11/7/2017	Sell	1,602	$215.70	$345,551.40	35,322
8/10/2017	Sell	524	$190.80	$99,979.20	36,924
5/24/2017	Sell	555	$180.56	$100,210.80	37,448

Julie A. Hill Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $365.96

$364.86

$372.00

50 Day Range

MA: $409.70

$365.96

$509.58

2 Week Range

Now: $365.96

$362.21

$567.26

Volume

3,438,138 shs

Average Volume

1,252,031 shs

Market Capitalization

$84.87 billion

P/E Ratio

13.34

Dividend Yield

1.78%

Beta

0.83

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.